Senescence-associated reprogramming promotes cancer stemness
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Cellular senescence is a stress-responsive cell-cycle arrest program that terminates the further expansion of (pre-)malignant cells. Key signalling components of the senescence machinery, such as p16 INK4a, p21 CIP1 and p53, as well as trimethylation of lysine 9 at histone H3 (H3K9me3), also operate as critical regulators of stem-cell functions (which are collectively termed 'stemness'). In cancer cells, a gain of stemness may have profound implications for tumour aggressiveness and clinical outcome. Here we investigated whether chemotherapy-induced senescence could change stem-cell-related properties of malignant cells. Gene expression and functional analyses comparing senescent and non-senescent B-cell lymphomas from Eμ-Myc transgenic mice revealed substantial upregulation of an adult tissue stem-cell signature, activated Wnt signalling, and distinct stem-cell markers in senescence. Using genetically switchable models of senescence targeting H3K9me3 or p53 to mimic spontaneous escape from the arrested condition, we found that cells released from senescence re-entered the cell cycle with strongly enhanced and Wnt-dependent clonogenic growth potential compared to virtually identical populations that had been equally exposed to chemotherapy but had never been senescent. In vivo, these previously senescent cells presented with a much higher tumour initiation potential. Notably, the temporary enforcement of senescence in p53-regulatable models of acute lymphoblastic leukaemia and acute myeloid leukaemia was found to reprogram non-stem bulk leukaemia cells into self-renewing, leukaemia-initiating stem cells. Our data, which are further supported by consistent results in human cancer cell lines and primary samples of human haematological malignancies, reveal that senescence-associated stemness is an unexpected, cell-autonomous feature that exerts its detrimental, highly aggressive growth potential upon escape from cell-cycle blockade, and is enriched in relapse tumours. These findings have profound implications for cancer therapy, and provide new mechanistic insights into the plasticity of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persistent senescent cells are known to exert detrimental long-term effects on organ function and can promote tumorigenesis33,96,112,177,178.”
From COVID-19 and cellular senescence (2023) · cites this paper as [177]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the senescence programme is associated with enhanced stemness through cell- autonomous and cell- non- autonomous mechanisms”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Continuous transcriptional or, more generally, functional changes in senescent cells, and the permanent need to actively maintain senescencesupporting transcription puts the stability of cell cycle arrest at risk, occasionally leading to the restoration of proliferative properties with a potentially detrimental effect on tumour suppression 5,79 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conversely, inactivation of Tp53 , the genes encoding either one of the three Rb family members or Suv39h1 in already senescent cells enables cell cycle re- entry out of the terminal arrest condition 5,125,126 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, retained senescence- associated gain of stemness in senescence escapers has been demonstrated in samples derived from patients with relapsed diffuse large B cell lymphoma that exhibited strong enrichment for WNT signalling activity reminiscent of senescence- associated stemness 5 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [5]
Experimental — accuracy not yet measured
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Rappsilber, J., Mann, M., & Ishihama, Y. (2007) · Nature Protocols · doi:10.1038/nprot.2007.261 · Cited by 4,641
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Cited by
Items 901–1,000 of 1,000
Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemia
Küchler, S., Brilloff, S., Schäfer, S., Rahimian, E., Kufrin, V., Peri, S. S., Musa, J., Grünewald, T. G. P., Schewe, D. M., Ball, C. R., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02810-4 · Cited by 1
Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma
Esaki, N., Sakoda, T., Ando, R., Miyai, Y., Iida, T., Mizutani, Y., Yoshida, M., Hara, Y., Matsuyama, M., Kobayashi, T., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03605-8 · Cited by 1
Peptide-Based Therapeutic Platforms for Addressing Drug Resistance in Breast Cancer
Meur, S., & Karati, D. (2025) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-025-10770-7 · Cited by 1
Semenova, N., Yakisich, J. S., Ascue, R., Iyer, A. K. V., & Azad, N. (2025) · Cells · doi:10.3390/cells14211667 · Cited by 1
Zhu, H., Pan, S., Zhou, Y., Yi, B., Jing, Y., Ruan, L., Huang, L., & Zhu, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-03854-9 · Cited by 1
Fungal Melanin as a Potential Geroprotector: First In Vitro Insights
Storozhenko, A. A., Kulikov, S. S., Mikheeva, U. A., Mishchenko, T. A., Vedunova, M. V., Moskalev, A., & Usoltseva, O. N. (2025) · Advances in Gerontology · doi:10.1134/s2079057025600417 · Cited by 1
Fujiwara, M., Shinji, S., Shichi, Y., Nonaka, K., Hasegawa, Y., Takahashi, K., Rokutan, H., Arai, T., & Ishiwata, T. (2025) · BMC Cancer · doi:10.1186/s12885-025-15317-z · Cited by 1
Kuang, Y., Jia, M., Zhu, Y., & Xiang, Z. (2026) · PeerJ · doi:10.7717/peerj.20476 · Cited by 1
Li, T., Huang, M., Cai, J., Li, X., Xing, Y., He, R., Wan, Z., Gan, Y., Li, Z., Weng, J., et al. (2026) · Advanced Science · doi:10.1002/advs.202518536 · Cited by 2
Nrf2 shapes response to lysosomal inhibition of radiation-induced senescent thyroid cancer cells
Mazzoleni, B., Mazzoni, M., Vergaro, D., Marco, T. D., Pagliardini, S., & Greco, A. (2026) · Endocrine Related Cancer · doi:10.1530/erc-25-0291 · Cited by 1
The Werner syndrome RECQ helicase as a therapeutic target: new insights
Sidorova, J. M., & Monnat, R. J. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2619753 · Cited by 1
Alshehri, M. A., Saleh, T., Anscher, M. S., Boyd, R. A., Harada, H., & Gewirtz, D. A. (2026) · Radiation Research · doi:10.1667/rade-25-00156.1 · Cited by 1
Lin, F., Pineda, E., McGonnigal, B., Wallace, J. R., Lu, W. J., Dennery, P. A., & Yao, H. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl48370 · Cited by 1
Zhang, M., Hu, Z., Piao, S., Song, Y., Jia, Y., Liu, J., Zhao, N. O., Liu, A., FU, S., Sun, W., et al. (2026) · Aging Cell · doi:10.1111/acel.70434 · Cited by 2
Dyskerin dysfunction in cancer development: from telomere dysregulation to immune deficiency
Xie, Y. (2026) · American Journal of Cancer Research · doi:10.62347/hjxs1407 · Cited by 1
Multifacet Roles of Cellular Senescence in Cancer: Mechanisms and Therapeutic Implications
Mao, H., Liu, W., Su, Y., Ma, Y., Zhao, X., & Lu, Y. (2026) · MedComm – Oncology · doi:10.1002/mog2.70060 · Cited by 1
Hematopoietic stem cell senescence and opportunities for intervention
Barve, A., Dabas, P., Cain, T. L., & McKinney‐Freeman, S. (2026) · Experimental Hematology · doi:10.1016/j.exphem.2026.105425 · Cited by 1
Zhang, X., Yang, L., He, X., Zhao, M., Fang, Z., Xu, G., Duan, Z., & Luo, K. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.03.050 · Cited by 2
To, S. K. Y., Yang, Y., Shi, Z., Fung, K., Lai, S. L., Li, J. J. X., Ip, P. P. C., & Wong, A. S. T. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08737-7 · Cited by 1
Yu, M., Duan, L., Huang, Y., Cheng, Y., Wang, Y., Huang, G., Lian, J., Chen, S., Wen, F., Guo, L., et al. (2026) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-1081 · Cited by 1
Shboul, S. A., Alrjoub, M., Karsaneh, O. A. A., Surakhy, M., Alhesa, A., El-Sadoni, M., Al-Sheyab, M., Alsoud, A., Friehat, K., Khasawneh, A. I., et al. (2026) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-026-04541-y · Cited by 1
Mayr, L., Mager, L., Gabler, L., Kirchhofer, D., Freund, J., Schwark, K., Lau, B. C., Machreich, S., Senfter, D., Neumüller, M., et al. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03725-3 · Cited by 1
Zeng, X., Yang, P., Wang, T., Shi, R., Qin, C., Zhang, L., Jiang, T., Chen, X., Luo, H., Wei, J., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1799765 · Cited by 1
Zhang, Y., Qian, S., Yang, Q., Shi, Z., Dong, M., Wang, Z., Yang, Z., Wu, S., Li, Z., Zhang, M., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08897-6 · Cited by 1
The love and hate relationship between cellular senescence and stemness
Papaspyropoulos, A., Theocharous, G., Ntintas, O. A., Evangelou, K., & Gorgoulis, V. G. (2026) · Aging · doi:10.18632/aging.206387 · Cited by 2
Sievers, C. M., Robbins, Y. L., Craveiro, M., Friedman, J., Huynh, A., Yang, X., Kelly, M. C., Hodge, J. W., Akbulut, D., Quezado, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74318-z · Cited by 1
Lu, Z., Li, Y., Zhu, Z., Li, F., Ding, Y., Ding, L., Wang, R., Lin, Y., Luo, W., Mao, X., et al. (2026) · International Journal of Biological Sciences · doi:10.7150/ijbs.131368 · Cited by 1
Senescence in non-cancerous cells within the tumor: What is the real deal?
Perramon‐Güell, A., & Anerillas, C. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189654 · Cited by 1
Zhang, L., Zhang, K. C., Chen, Z. F., & Xh, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1907838 · Cited by 1
Xu, Z., Guo, J., Liu, Z., Yu, J., Yuan, R., Min, Y., Wei, Z., & Peng, X. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103270 · Cited by 1
Brain Aging and Cellular Senescence Trigger Neuroimmunological Dysregulation and Neurodegeneration
Vega-García, A., Apolinar, L. M., Feria-Romero, I. A., Campos‐Bedolla, P., Alberto, G.-G. C., Luna‐Munguía, H., Sofía, R.-H., & Orozco-Suárez, S. A. (2026) · Brain Sciences · doi:10.3390/brainsci16101019 · Cited by 1
Murray, G. F., Turner, T. H., Saleh, T., Alzubi, M. A., Toor, A. A., Gewirtz, D. A., Harrell, J. C., & Reed, J. C. (2019) · Quantitative Phase Imaging · doi:10.1117/12.2514597 · Cited by 1
Senescence-Associated Beta-Galactosidase Marker of Cellular Senescence
Dimri, M., & Dimri, G. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11446-1 · Cited by 1
Binenbaum, I., Lefaki, M., Chondrogianni, N., & Chatziioannou, A. A. (2020) · Biogerontology · doi:10.1007/s10522-020-09866-y · Cited by 1
Is Tumorigenesis an Abiogenesis?
Hugwil, A. V. (2019) · Open Access Journal of Cancer & Oncology · doi:10.23880/oajco-16000139 · Cited by 1
Preventing phenotypic plasticity in cancer to mitigate therapy resistance
Coatham, M. L., Jewer, M., & Postovit, L.-M. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821310-0.00002-4 · Cited by 1
González‐Gualda, E., Ou, H., Macías, D., & Muñoz‐Espín, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00016-x · Cited by 2
To G0 or Not to G0: Cell Cycle Paradox in Senescence and Brain Aging
Ishikawa, S., & Ishikawa, F. (2022) · Springer eBooks · doi:10.1007/978-981-16-7977-3_5 · Cited by 1
Is anti-PD-1 immunotherapy a means for post-irradiation tumor clearance in head and neck cancer?
Koukourakis, I. M., Papadimitriou, M., Desse, D., Zygogianni, A. G., PAPADIMITRIOU, C. A., & Koukourakis, M. I. (2022) · Medical Oncology · doi:10.1007/s12032-022-01778-w · Cited by 1
The Role of lncRNAs and miRNAs in Therapy-Induced Senescence in Neuroblastoma
Jahangiri, L., & Ishola, T. (2022) · Current Molecular Biology Reports · doi:10.1007/s40610-022-00149-8 · Cited by 1
Diagnostic and Prognostic Significance of Cancer Stem Cell Surface Markers
Aktar, S., Islam, M. S., Gopalan, V., Lam, A. K.-Y., & Islam, F. (2023) · Springer eBooks · doi:10.1007/978-981-99-3185-9_17 · Cited by 1
Ma, Z., Han, H., Zhou, Z., Wang, S., Liang, F., Wang, L., Ji, H., Yang, Y., & Chen, J. (2023) · IUBMB Life · doi:10.1002/iub.2768 · Cited by 1
Wang, Z., Chen, Q., Zhao, F., Sun, L., Qiu, Y., Cheng, H., Qin, J., Wang, H., Shi, S., Cao, S., et al. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad168 · Cited by 1
Palmer, A. K., & Kirkland, J. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15500-0.00012-8 · Cited by 2
Suppressing the Aging Phenotype of Mesenchymal Stromal Cells: Are We Ready for Clinical Translation?
Roato, I., Visca, M., & Mussano, F. D. (2024) · Biomedicines · doi:10.3390/biomedicines12122811 · Cited by 1
Ain, Q. U. (2024) · Asia-Pacific Journal of Oncology · doi:10.32948/ajo.2024.12.25 · Cited by 2
Persistence and/or Senescence: Not So Lasting at Last?
Schmitt, C. A. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3744 · Cited by 1
Self-citationSenescence and the Microenvironment
Rai, M. K., Yadav, P., Katailiha, A. S., Singh, A. K., & Yadav, S. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-1041-9_3 · Cited by 2
Chang, O., Cheon, S., Semenova, N., Azad, N., Iyer, A. K. V., & Yakisich, J. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062720 · Cited by 1
A novel platform for precise senolysis
Conti, A., & Micco, R. D. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112056 · Cited by 2
CircRNAs Regulate Senescence-Associated miRNAs in Gastric Cancer
Chen, S., Yang, X., Lei, X., & Tang, H. (2025) · Current Cancer Drug Targets · doi:10.2174/0115680096365738250618201121 · Cited by 2
Paksee, S., Kantapan, J., Chawapun, P., Sangthong, P., Paksee, N. D., Kantapan, J., Chawapun, P., Sangthong, P., & Dechsupa, N. (2019) · Journal of Associated Medical Sciences · doi:10.14456/jams.2019.27 · Cited by 1
Li, X., Li, Y., Zhang, L., Mao, J., & Li, B. (2026) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303420035251023051847 · Cited by 1
Stemness and Relapse: “Chicken or the Egg” Question
Tesio, M. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000554 · Cited by 1
Clinical expression and prognosis of SUV39H1 in diffuse large B-cell lymphomaPreprint
Zhang, Y., Wen, Q., Lei, Y., Ge, J.-J., Kong, X.-S., Wang, W., Wang, Z., Hou, H., Qian, S., Wu, S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-418357/v1 · Cited by 1
He, A., Xiang, D., Kopper, O., Horan, D. J., Chen, P., Bronson, R. T., Sheng, R., Wu, H., Sui, L., Zhou, K., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-58989/v1 · Cited by 1
Current Research On Epigenetic Age and Cellular Senescence: A Bibliometric and Visual AnalysisPreprint
kahaer, M. M. M., Hao, B. M. W., Sun, M. M. Z.-G., Xu, M. M. K., & Aikeremu, M. M. D. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.13.580124 · Cited by 1
The role of centromere dysfunction in genome instability
Hervé, S. (2020) · theses.fr (ABES) · doi:10.70675/689b182dz8281z4d70za0aaz675792ec7d76 · Cited by 1
Jatal, R. (2021) · theses.fr (ABES) · doi:10.70675/7299ae44z37f8z4e79z8e0dz67e48edb7144 · Cited by 3
Pareri, A. U., Losito, M., Foijer, F., & Saurin, A. T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.01.662622 · Cited by 1
Jamil, N., Hooker, Q., Cornejal, N., Hosgood, H. D., & McDaid, H. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.07.704600 · Cited by 1
Age-dependent sensitivity to antimitotics: the role of FOXM1 and its therapeutic potential
Vaz, S. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/gq0b-fc14
Agius, L. M. (2018) · Cancer therapy & Oncology International Journal · doi:10.19080/ctoij.2018.09.555755
Bessa, T. C. D. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-03072018-090616
A novel Sudan Black B-based analogue revives lipofuscin as a biomarker for in vivo senescence
TINIAKOS, D. G., & Jurk, D. (2018) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-018-2452-8
Chakradhar, S. (2019) · Nature Medicine · doi:10.1038/d41591-019-00004-x
Identification of Essential Genes in Hepatocellular Carcinomas using CRISPR Screening
Sheel, A. (2019) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/hv7r-q398
Wang, L., Mu, H., Lin, Z. H., Zhang, L. L., Xu, Y., & Liu, H. (2020) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2020.02.013
Wicaksono, B. D. (2020) · ERA · doi:10.7488/era/429
Birth and death of cellular senescence
Wang, B. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.131223530
ROLE OF CANCER STEM CELLS IN OVARIAN CARCINOGENESIS
Gening, S., & Antoneeva, I. I. (2020) · Ulyanovsk Medico-biological Journal · doi:10.34014/2227-1848-2020-3-82-103
Xian-hong, X., Fu, Y., Zhang, X., Miao, R., Ma, X., Liu, C., & Qu, K. (2021) · Research Square · doi:10.21203/rs.3.rs-215294/v1
El-shaer, N. H., Eldeen, M. A., Hashem, A. M., Eid, R. A., & Raafat, N. (2021) · Systematic Reviews in Pharmacy · doi:10.31838/srp.2021.3.92
A novel transcriptomic-based classifier for senescent cancer cells
Varughese, F. M., & Demaria, M. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.09.001
Novel probes, carriers and prodrugs to target senescent cells in vivo
Lozano‐Torres, B. (2021) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/172175
杉山, 徹., 村上, 文., & 嘉村, 敏. (2002) · 日本産科婦人科學會雜誌
Martínez‐Zamudio, R. I., & Herbig, U. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_38
Alvarez-Buylla, E. R., Martínez‐García, J. C., Dávila-Velderrain, J., Domínguez‐Hüttinger, E., & Martínez-Sánchez, M. E. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-89354-9_3
An Insight of Autophagy and Cellular Senescence: One Promising Approach for Senescence Delaying
(2022) · Journal of Contemporary Medical Practice · doi:10.53469/jcmp.2022.04(03).11
Clinical Expression, Prognosis and Immune Infiltration of SUV39H1 in Diffuse Large B-cell LymphomaPreprint
Zhang, Y., Wen, Q., Lei, Y., Ge, J., Kong, X., Wang, W., Wang, Z., Hou, H., Qian, S., Tang, C., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-418357/v2
Gold, M. R. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734674689.793558446
Cleton-Jansen, A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736693821.793566748
Pawelec, G. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734674689.793557283
Response to the letter by Dr. Renba Liang
George, J., Zhou, G., & Qiao, L. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215650
Proteomic analysis of human keratinocytes under UVA-induced stress
Valerio, H. P. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2021.tde-28042022-144138
Scott, M. (2022) · Edinburgh University Press eBooks · doi:10.1515/9781474486194-013
Dovjak, E., Mairhofer, M., Wöß, C., Qi, J., Fan, D. N.-Y., Schmitt, C. A., & Yu, Y. (2022) · Journal of Visualized Experiments · doi:10.3791/63973
Self-citationZheng, Q., Tan, J., Wang, T., Chen, J., Gong, J., Li, K., & Liang, Y. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4095863
An Overview of the Role of Senescence in Cancer
Al-Janabi, I. I. (2022) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v3i.77
Cellular senescence during aging
von Zglinicki, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00017-3 · Cited by 1
Preclinical evaluation of senescence-based strategies to improve cancer therapy
Estepa‐Fernández, A. (2022) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/188845
Fletcher-Sananikone, E., Kanji, S., Tomimatsu, N., Cristofaro, L. F. M. D., Kollipara, R. K., Saha, D., Floyd, J., Sung, P., Hromas, R., Burns, T. C., et al. (2023) · doi:10.1158/0008-5472.c.6513888.v1
Wuestefeld, A., Iakovleva, V., Yap, S. X. L., Ong, A. B. L., Huang, D. Q., Shuen, T. W. H., Toh, H. C., Dan, Y. Y., Zender, L., & Wüestefeld, T. (2023) · doi:10.1158/0008-5472.c.6514362
Berghoff, A. S., Liao, Y., Karreman, M. A., Ilhan‐Mutlu, A., Gunkel, K., Sprick, M. R., Eisen, C., Kessler, T., Osswald, M., Wünsche, S., et al. (2023) · doi:10.1158/1541-7786.c.6545246
Self-citationData from Senescence Rewires Microenvironment Sensing to Facilitate Antitumor Immunity
Chen, H.-A., Ho, Y.-J., Mezzadra, R., Adrover, J. M., Smolkin, R. M., Zhu, C., Woess, K., Bernstein, N., Schmitt, G., Fong, L. E., et al. (2023) · doi:10.1158/2159-8290.c.6549996
Berghoff, A. S., Liao, Y., Karreman, M. A., Ilhan‐Mutlu, A., Gunkel, K., Sprick, M. R., Eisen, C., Kessler, T., Osswald, M., Wünsche, S., et al. (2023) · doi:10.1158/1541-7786.c.6545246.v1
Self-citationThe Molecular Mechanisms of Cellular Senescence Induced by Enzalutamide in LNCaP Cells
冯, 诗. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1351088
Metadata
- Authors
- Milanovic, M., Fan, D. N. Y., Belenki, D., Däbritz, J. H. M., Zhao, Z., Yu, Y., Dörr, J. R., Dimitrova, L., Lenze, D., Monteiro Barbosa, I. A., Mendoza-Parra, M. A., Kanashova, T., Metzner, M., Pardon, K., Reimann, M., Trumpp, A., Dörken, B., Zuber, J., Gronemeyer, H., Hummel, M., Dittmar, G., Lee, S., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- German Cancer Research Center (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Max Delbrück Center (DE)
- Centre National de la Recherche Scientifique (FR)
- Research Institute of Molecular Pathology (AT)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2017-12-20
- Volume
- 553
- Issue
- 7686
- Pages
- 96-100
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777786283
- Cited by
- 1,131
- References
- 60
- Citations by year
- 2026: 110 · 2025: 137 · 2024: 154 · 2023: 181 · 2022: 149 · 2021: 140 · 2020: 125 · 2019: 84 · 2018: 49 · 2017: 1
- FWCI
- 52.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, cancer stem cells, chemotherapy-induced senescence, senescence escape, Wnt signaling, H3K9me3, p53, p16INK4a, p21, B-cell lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, hematologic malignancies, clonogenic growth, self-renewal
- MeSH terms
- Animals, Clone Cells, Female, Humans, Male, Mice, Transgenic, Phenotype, Neoplastic Stem Cells, Biomarkers, Lymphoma, B-Cell, Cellular Senescence, Cell Line, Tumor, Cell Proliferation, Mice, Cell Cycle Checkpoints, Wnt Signaling Pathway, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.